|
41
|
Product specific BE guideline |
Zolpidem Tartrate Tablet_生體相等性試驗指導原則
|
2020-07-21 |
|
42
|
Product specific BE guideline |
Agomelatine Tablet_生體相等性試驗指導原則
|
2019-10-01 |
|
43
|
Product specific BE guideline |
Entecavir Tablet_生體相等性試驗指導原則
|
2019-10-01 |
|
44
|
Product specific BE guideline |
Levofloxacin Tablet_生體相等性試驗指導原則
|
2019-10-01 |
|
45
|
Product specific BE guideline |
Methylphenidate ER Tablet_生體相等性試驗指導原則
|
2019-10-01 |
|
46
|
Product specific BE guideline |
Oseltamivir Phosphate capsule_生體相等性試驗指導原則
|
2019-10-01 |
|
47
|
Product specific BE guideline |
Pazopanib tablet_生體相等性試驗指導原則
|
2019-10-01 |
|
48
|
Product specific BE guideline |
Sitagliptin phosphate tablet_生體相等性試驗指導原則
|
2019-10-01 |
|
49
|
Product specific BE guideline |
Tenofovir Disoproxil Fumarate Tablet_生體相等性試驗指導原則
|
2019-10-01 |
|
50
|
Product specific BE guideline |
Ezetimibe+Simvastatin Tablets_生體相等性試驗指導原則_v2(新增QA)
|
2019-10-01 |
